Extended follow-up of outcome measures in multiple myeloma patients treated on a phase I study with bortezomib and pegylated liposomal doxorubicin

Author: Biehn Suzanne   Moore Dominic   Voorhees Peter   Garcia Reynaldo   Lehman Mary   Dees E.   Orlowski Robert  

Publisher: Springer Publishing Company

ISSN: 0939-5555

Source: Annals of Hematology, Vol.86, Iss.3, 2007-03, pp. : 211-216

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content